Dysregulation of HNF1B/Clusterin axis enhances disease progression in a highly aggressive subset of pancreatic cancer patients.
Yang S, Tang W, Azizian A, Gaedcke J, Ströbel P, Wang L, Cawley H, Ohara Y, Valenzuela P, Zhang L, Lal T, Sinha S, Rupin E, Hanna N, Ghadimi BM, Hussain SP.
Yang S, et al. Among authors: lal t.
Carcinogenesis. 2022 Dec 31;43(12):1198-1210. doi: 10.1093/carcin/bgac092.
Carcinogenesis. 2022.
PMID: 36426859
Free PMC article.